A detailed history of Essex Investment Management CO LLC transactions in Evolus, Inc. stock. As of the latest transaction made, Essex Investment Management CO LLC holds 295,553 shares of EOLS stock, worth $3.51 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares
295,553
Previous 294,442 0.38%
Holding current value
$3.51 Million
Previous $3.19 Million 49.87%
% of portfolio
0.89%
Previous 0.63%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$10.66 - $17.48 $11,843 - $19,420
1,111 Added 0.38%
295,553 $4.79 Million
Q2 2024

Aug 12, 2024

BUY
$10.45 - $13.76 $414,143 - $545,322
39,631 Added 15.55%
294,442 $3.19 Million
Q1 2024

May 03, 2024

BUY
$9.99 - $14.91 $37,572 - $56,076
3,761 Added 1.5%
254,811 $3.57 Million
Q4 2023

Feb 07, 2024

SELL
$7.6 - $10.53 $180,530 - $250,129
-23,754 Reduced 8.64%
251,050 $2.64 Million
Q3 2023

Nov 09, 2023

SELL
$7.15 - $10.2 $25,554 - $36,454
-3,574 Reduced 1.28%
274,804 $2.51 Million
Q2 2023

Aug 14, 2023

BUY
$7.23 - $10.52 $229,415 - $333,810
31,731 Added 12.86%
278,378 $2.02 Million
Q1 2023

May 04, 2023

BUY
$7.81 - $11.05 $263,595 - $372,948
33,751 Added 15.85%
246,647 $2.09 Million
Q4 2022

Feb 02, 2023

SELL
$6.52 - $8.95 $1.01 Million - $1.39 Million
-155,450 Reduced 42.2%
212,896 $1.6 Million
Q3 2022

Nov 14, 2022

BUY
$7.76 - $13.72 $43,184 - $76,351
5,565 Added 1.53%
368,346 $2.97 Million
Q2 2022

Aug 12, 2022

SELL
$10.22 - $13.94 $90,334 - $123,215
-8,839 Reduced 2.38%
362,781 $4.21 Million
Q1 2022

May 09, 2022

BUY
$5.22 - $11.78 $1.94 Million - $4.38 Million
371,620 New
371,620 $4.17 Million

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $666M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Essex Investment Management CO LLC Portfolio

Follow Essex Investment Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex Investment Management CO LLC with notifications on news.